AS SEEN IN:

FDA Grants Orphan Drug Designation to Biompharma’s Bi104, a microbiome-modifying biologic, for the treatment of Angelman Syndrome

Sarasota, Florida, May 08, 2024 (GLOBE NEWSWIRE) — BIOM Pharmaceutical Corporation is thrilled to announce that Bi104, its innovative drug product, has been granted orphan-drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of Angelman syndrome (AS). Read more

VagiBiom Expands Product Line in Walmart Stores Nationwide

VagiBiom a trusted name in women’s health and wellness, is pleased to announce the expansion of its product line in Walmart stores across the country and online at Walmart.com. Previously known for its Fragrance-Free suppositories, VagiBiom is now introducing an array of new offerings to cater to the diverse needs of its customers. Read more

 VagiBiom® Feminine Support Suppositories Are Now Available in Publix Stores

BIOM Pharmaceutical Corporation (BIOM), a biotech company focused on natural microbiome-based consumer and medical products, today announced that it has launched two VagiBIOM® feminine care products in Publix, a leading supermarket and grocery chain in the Southeast United States with 1367 stores. Read more

vagibiom-product-image

Biom Pharmaceutical Published Clinical Safety & Efficacy of VagiBiom® Microbiome-based Probiotic Suppositories for Intimate Women’s Health

VagiBiom® microbiome-based probiotic suppositories have shown to be safe and efficacious in significantly improving symptoms and the vaginal health index in reproductive age and perimenopausal women with Bacterial Vaginosis. Read more

FDA Grants Orphan Drug Designation to Biompharma’s Bi104, a microbiome-modifying biologic, for the treatment of Angelman Syndrome

Sarasota, Florida, May 08, 2024 (GLOBE NEWSWIRE) — BIOM Pharmaceutical Corporation is thrilled to announce that Bi104, its innovative drug product, has been granted orphan-drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of Angelman syndrome (AS). Read more

VagiBiom Expands Product Line in Walmart Stores Nationwide

VagiBiom a trusted name in women’s health and wellness, is pleased to announce the expansion of its product line in Walmart stores across the country and online at Walmart.com. Previously known for its Fragrance-Free suppositories, VagiBiom is now introducing an array of new offerings to cater to the diverse needs of its customers. Read more

VagiBiom® Feminine Support Suppositories Are Now Available in Publix Stores

BIOM Pharmaceutical Corporation (BIOM), a biotech company focused on natural microbiome-based consumer and medical products, today announced that it has launched two VagiBIOM® feminine care products in Publix, a leading supermarket and grocery chain in the Southeast United States with 1367 stores. Read more

vagibiom-product-image

Biom Pharmaceutical Published Clinical Safety & Efficacy of VagiBiom® Microbiome-based Probiotic Suppositories for Intimate Women’s Health

VagiBiom® microbiome-based probiotic suppositories have shown to be safe and efficacious in significantly improving symptoms and the vaginal health index in reproductive age and perimenopausal women with Bacterial Vaginosis. Read more

Gardner Joins BIOM Pharmaceutical as Board Chairman

BIOM Pharmaceutical Corporation, an emerging biotech company focused on human microbiome technologies, is pleased to announce the appointment of Thomas E. Gardner as Chairman of the BIOM Board of Directors. Read more

Biom pharmaceuticals

Gardner Joins BIOM Pharmaceutical as Board Chairman

BIOM Pharmaceutical Corporation, an emerging biotech company focused on human microbiome technologies, is pleased to announce the appointment of Thomas E. Gardner as Chairman of the BIOM Board of Directors. Read more

Microbiome Research Company Biom Pharmaceutical Launches Vee Mobile App To Maintain Optimal Feminine Health At Every Stage

Biom Pharmaceutical, a leading microbiome research company and creator of femtech brand VagiBiom® (Vaginal Microbiome), has just launched Vee, a female-focused mobile health app that supports women’s health at each stage of the female journey. Read more

Microbiome Research Company

Microbiome Research Company Biom Pharmaceutical Launches Vee Mobile App To Maintain Optimal Feminine Health At Every Stage

Biom Pharmaceutical, a leading microbiome research company and creator of femtech brand VagiBiom® (Vaginal Microbiome), has just launched Vee, a female-focused mobile health app that supports women’s health at each stage of the female journey. Read more

Biom Pharmaceutical Launches VagiBiom®(Vaginal Microbiome)Feminine Probiotics Product in All Walmart Stores

Biom Pharmaceuticals’ VagiBiom®(Vaginal Microbiome)feminine product is now available in all Walmart stores. This novel microbiome-focused formulation was presented at Walmart’s Made in USA Open Call competition in October 2020 and got selected for launch in all Walmart stores. Read more

vagi_biom2

Biom Pharmaceutical Launches VagiBiom®(Vaginal Microbiome)Feminine Probiotics Product in All Walmart Stores

Biom Pharmaceuticals’ VagiBiom®(Vaginal Microbiome)feminine product is now available in all Walmart stores. This novel microbiome-focused formulation was presented at Walmart’s Made in USA Open Call competition in October 2020 and got selected for launch in all Walmart stores. Read more